ANIX: Catelani Michael discloses a purchase
By AlphaYouPublished Form 4
Catelani Michael
Reporting filer
Catelani Michael reported Purchase in Anixa Biosciences Inc: 5500 units of Common Stock, dated 2026-09-30. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 30, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Catelani Michael | 2026-09-30 | P | Purchase | 5500 | 2.84 | 50,000 | 0 days | Filed terms
|
Common Stock
- Owner
- Catelani Michael
- Date
- 2026-09-30
- Code
- P
- Action
- Purchase
- Quantity
- 5500
- Price
- 2.84
- Following holdings
- 50,000
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-30
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 5500
- transaction Price Per Share: 2.84
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 50000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Catelani Michael: President, COO, & CFO.
Original sources
Prepared automatically from public filing data. Report a correction.